1. Home
  2. ALLR vs EBON Comparison

ALLR vs EBON Comparison

Compare ALLR & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$0.79

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

HOLD

Current Price

$1.42

Market Cap

16.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLR
EBON
Founded
2004
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
19.3M
16.0M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ALLR
EBON
Price
$0.79
$1.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 136.5K
8.6K
Earning Date
11-13-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $320,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$1.35
52 Week High
$1.84
$3.89

Technical Indicators

Market Signals
Indicator
ALLR
EBON
Relative Strength Index (RSI) 38.05 34.85
Support Level N/A $1.35
Resistance Level $1.45 $2.34
Average True Range (ATR) 0.09 0.17
MACD -0.01 -0.02
Stochastic Oscillator 3.70 11.80

Price Performance

Historical Comparison
ALLR
EBON

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is engaged in blockchain technology and fintech, with activities also extending to the solar industry, supported by its application-specific integrated circuit (ASIC) chip designs. The Company's business mainly includes the sale of bitcoin mining machines and related accessories, telecommunication products, solar and battery storage products, cryptocurrency exchange services, cross-border payment and foreign exchange services, SaaS data visualization and analytics solutions, and rental services. It generates the majority of its revenue from cross-border payment and foreign exchange services, with its operations mainly in mainland China and Australia, which contribute the maximum revenue.

Share on Social Networks: